Indicated for: cancer
Route of administration: infusion
Substance: docetaxel (taxane antineoplastic)
ATC: L01CD02 (Antineoplastic and immunomodulating agents | Plant alkaloids and other natural products | Taxanes)
Docetaxelum is a chemotherapy drug used for the treatment of various types of cancer, including breast cancer, lung cancer, and prostate cancer. It belongs to the taxane class and works by inhibiting cell division, preventing the growth and spread of cancer cells.
The medication is administered intravenously, usually as part of a specific regimen, under the supervision of an oncologist. It is effective in reducing tumor size and prolonging patient survival.
Side effects may include nausea, vomiting, hair loss, neutropenia, and, in rare cases, severe allergic reactions. Close monitoring is essential during treatment.
Consult your doctor to discuss the benefits and risks of treatment with Docetaxelum. This medication must be administered exclusively in controlled environments, such as hospitals.